Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
miRNA in multiple sclerosis: search for novel biomarkers.
[Inflammatory brain pseudotumor. A variant of demyelinating disease that simulates high-grade glioma].
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis.
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Paroxysmal Hypothermia in Two Patients with Multiple Sclerosis.
Inhibition of Interferon-beta Responses in Multiple Sclerosis Immune Cells Associated With High-Dose Statins.
Distribution of Brain Sodium Accumulation Correlates with Disability in Multiple Sclerosis: A Cross-sectional 23Na MR Imaging Study.
Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases.
Fampridine – Benefit assessment according to § 35a Social Code Book V
Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.
Epidermal pigmentation in the human lineage is an adaptation to ultraviolet radiation.
The microglial sensome revealed by direct RNA sequencing.
The value of the multiple sclerosis specialist nurse with respect to prevention of unnecessary emergency admission.
Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter.
Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome.
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.
Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.
Building a better sphingosine kinase-1 inhibitor.
The unwavering commitment of regulatory T cells in the suppression of autoimmune encephalomyelitis: Another aspect of immune privilege in the CNS.
A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city.
Patterns of Retinal Damage Facilitate Differential Diagnosis between Susac Syndrome and MS.
[Immunodepressive therapy in neurology].
Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis.
Immune cell trafficking from the brain maintains CNS immune tolerance.
Santhera Receives European Marketing Authorization for Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Pages
« first
‹ previous
…
174
175
176
177
178
179
180
181
182
…
next ›
last »